Health-related quality of life and estimation of minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom (FACT-ES) score in postmenopausal ER-positive, HER2-negative metastatic breast cancer with low sensitivity to endocrine therapy